Rav Purewal

Rav Purewal is an associate in the Firm’s Corporate Department. Rav’s practice focuses on corporate transactions and governance matters, with experience advising clients across a range of industries and throughout the life cycle of their businesses.

She has significant experience in:

• Mergers and acquisitions
• Venture capital and private equity financings
• Corporate governance and entity formation
• Securities law and compliance
• Real estate transactions

Before joining Glaser Weil, Rav practiced at a large international law firm, where she represented public and private companies in venture capital financings, capital markets transactions, acquisitions, and other strategic deals. She also counseled boards and senior management on U.S. securities law and Nasdaq/NYSE compliance. Most recently, Rav was an associate at a Beverly Hills law firm, where she advised clients on mergers and acquisitions, corporate formations, governance matters, and commercial real estate transactions.

Rav’s notable matters include her representation of:

• The buyer in the $525 million carve-out of Real Alloy, Inc., the aluminum recycling division of Aleris, Inc.*
• EQRx, Inc., a biopharmaceutical company, in its all-stock acquisition by Revolution Medicines, Inc. (Nasdaq: RVMD)*
• A biotech company in its $150 million Series B financing round*
• A real estate developer in its acquisition of storage facilities in multiple states*
• A biotech company in its underwritten public offering of approximately $140.6 million*
• A pharmaceutical company in an “at-the-market” offering for the sale of up to $145 in shares*

*Denotes prior firm experience

Awards and Recognition

Best Lawyers: Ones to Watch® in America, 2026